← Back to Search

Procedure

GentleWave vs. Waterlase for Root Canal Treatment

N/A
Waitlist Available
Led By Glenn Karunanayake, BDS, MS
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from time of treatment completion to 12-month follow-up appointment, assessed up to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing two new methods, GentleWave® System and Waterlase iPlus®, for cleaning root canals. These methods use sound waves and lasers to clean teeth more effectively than traditional techniques. The trial targets patients with difficult-to-treat root canal infections to see if these new methods improve treatment success. The GentleWave® System has been shown to result in a higher tissue dissolution rate and is effective against harmful substances in infected root canals.

Who is the study for?
This trial is for males and females aged 14-99 with a permanent tooth needing root canal treatment due to pulp disease or infection, who can consent to the procedure. It's not for those with teeth that can't be restored, have high mobility or deep periodontal pockets, fractures, open apices, certain anatomical challenges, need multiple RCTs, allergies to anesthetics or severe systemic diseases.
What is being tested?
The study compares new root canal irrigation methods: GentleWave System (GWS) and Waterlase iPlus (WL), against conventional passive ultrasonic activation (PUI). It aims to see which method gives better results and how patients and clinicians feel about them.
What are the potential side effects?
While specific side effects are not listed here, typical risks of root canal treatments include discomfort during/after the procedure, swelling in treated area, potential damage to surrounding teeth/gums from equipment use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from time of treatment completion to 12-month follow-up appointment, assessed up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from time of treatment completion to 12-month follow-up appointment, assessed up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Periapical index score
Secondary study objectives
Qualitative data from patient and provider questionnaires about treatment procedure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Waterlase groupExperimental Treatment1 Intervention
Participants receive Waterlase iPlus for endodontic irrigation treatment and will be followed for 12 months after treatment to assess radiographic healing of the periapex and clinical healing of the tooth.
Group II: GentleWave groupExperimental Treatment1 Intervention
Participants receive GentleWave System for endodontic irrigation treatment and will be followed for 12 months after treatment to assess radiographic healing of the periapex and clinical healing of the tooth.
Group III: Control groupActive Control1 Intervention
Participants receive passive ultrasonic irrigation for endodontic irrigation treatment and will be followed for 12 months after treatment to assess radiographic healing of the periapex and clinical healing of the tooth.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The GentleWave® System and Waterlase iPlus® are advanced irrigation techniques used in root canal treatments to enhance the cleaning and disinfection of the root canal system. The GentleWave® System uses a combination of multisonic energy and fluid dynamics to remove bacteria, debris, and tissue from the entire root canal system, including the microscopic spaces that traditional methods might miss. Waterlase iPlus® employs laser energy and water to achieve similar results, effectively cleaning and shaping the root canal while minimizing damage to surrounding tissues. These advanced techniques are important for root canal patients because they increase the likelihood of a successful treatment by thoroughly disinfecting the root canal, reducing the risk of infection, and promoting better healing outcomes.
Efficiency of diode laser and ultrasonic-activated irrigation in retreatment of gutta percha and bioceramic sealer: An in vitro study.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,555 Previous Clinical Trials
4,298,413 Total Patients Enrolled
Glenn Karunanayake, BDS, MSPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

GentleWave System (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05555043 — N/A
Root Canal Research Study Groups: Waterlase group, Control group, GentleWave group
Root Canal Clinical Trial 2023: GentleWave System Highlights & Side Effects. Trial Name: NCT05555043 — N/A
GentleWave System (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05555043 — N/A
~0 spots leftby Nov 2024